![Alice Roudot-Ketelers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 332 525 $ al 31/05/2026
Alice Roudot-Ketelers worked as Vice President-Clinical Development at Genfit SA in 2021.
Prior to that, worked as VP-Pharmaceutical & Clinical Development at Inventiva SA. Education includes a graduate degree from the University of Lyon and a doctorate from Université De Lille.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INVENTIVA SA 0,03 % | 01/03/2025 | 66.500 ( 0,03 % ) | 332 525 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| GENFIT | Corporate Officer/Principal | 01/07/2021 |
| INVENTIVA | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Université De Lille
 Université De Lille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
